Experimental Study of Antidepressant Properties of Afobazole

Bull Exp Biol Med. 2023 May;175(1):59-62. doi: 10.1007/s10517-023-05811-4. Epub 2023 Jun 20.

Abstract

We studied the effects of oral administration of Afobazole in a dose of 10 mg/kg for 5 days on depressive-like behavior of male C57BL/6 mice in the tail suspension test in comparison with amitriptyline (10 mg/kg) or fluoxetine (20 mg/kg) treatment. Afobazole produced an antidepressant effect similar to amitriptyline, but inferior to fluoxetine. The σ1 receptor antagonist BD-1047 in a dose of 5 mg/kg blocked the antidepressant effect of Afobazole, which indicates the involvement of σ1 receptors in the antidepressant effect of the drug.

Keywords: Afobazole; BD-1047; C57BL/6 mice; depressive-like behavior; σ1 receptors.

MeSH terms

  • Amitriptyline* / pharmacology
  • Animals
  • Antidepressive Agents / pharmacology
  • Fluoxetine* / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL

Substances

  • Fluoxetine
  • 2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole
  • Amitriptyline
  • Antidepressive Agents